Marya Hynes
Chief of the Inter-American Observatory on Drugs

The Inter-American Observatory on Drugs, commonly known by its Spanish language acronym, OID, is the research unit of the Executive Secretariat of CICAD, providing support to OAS member states in the collection and analysis of data on the drug problem so that they can design more effective national drug policies. Among its activities, the OID:

  • Prepares and publishes reports on drug use in the Americas and supports national surveys and publications.
  • Develops and disseminates standardized protocols for the collection of data and the implementation of drug- related studies.
  • Promotes strong national drug observatories that use standardized data collection methods.
  • Supports the establishment of drug information networks (DIN) and early warning systems (EWS) to improve drug-related data collection, analysis, and dissemination.






see more see less
More Publications
Highlighted Publications
December, 2023
The Impact of the COVID-19 Pandemic on the Drug Problem in the Americas
November, 2023
The Emerging Threat of Xylazine in the Americas
October, 2023
Current Trends of Methamphetamine Use and Implications in North America
September, 2023
Online Sales of Illicit Substances in the Americas
July, 2023
Wastewater-based Epidemiology for Monitoring Drug Use
March, 2023
Cannabis with a High Concentration of Tetrahydrocannabinol (THC) and Synthetic Cannabinoids in Latin America and the Caribbean
Information Bulletin on High-Concentration Cannabis and Synthetic Cannabis
March, 2023
North American Trends in Fentanyl Use, Production, and Supply
Information Bulletin on Fentanyl
November, 2022
Report on Drug Supply in the Americas 2022
The report provides an overview of trends and patterns in drug supply across the Hemisphere.
March, 2023
Information Bulletin - Early Warning System of the Americas (SATA)
December, 2019
Report on Drug Use in the Americas 2019
December, 2023
Characteristics of Persons Seeking Drug Treatment in the Caribbean
January, 2019
Drug Adulterants and Their Effects on the Health of Users: a Critical Review
February, 2019
Standardized Indicators for National Drug Information Networks in Latin America
Strategic Partners